Description
LXH254 is a type II RAF inhibitor.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LXH254 is a type II RAF inhibitor.
| Cas No. | 1800398-38-2 |
|---|---|
| Purity | ≥99% |
| Formula | C25H25F3N4O4 |
| Formula Wt. | 502.49 |
| IUPAC Name | N-[3-[2-(2-hydroxyethoxy)-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide |
| Synonym | Naporafenib |
| Appearance | White powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Monaco K, Delach S, Yuan J, et al. LXH254, a potent and selective ARAF-sparing inhibitor of BRAF and CRAF for the treatment of MAPK-driven tumors. Clin Cancer Res. 2021 Apr 1;27(7):2061-2073. PMID: 33355204
Park S, Kim T, Cho S, et al. Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells. Cancer Lett. 2020 Dec 28;495:135-144. PMID: 32979462
Mixture of taxanes.
β-adrenergic agonist.
Endogenous peptide fragment, immunostimulant; ...
Synthetic kahweol derivative.
Diterpene found in coffee beans.
May induce apoptosis in lymphoma cell lines.
Polyketide; DNMT 1 inhibitor, RNA synthesis inh...
STING antagonist
Mycotoxin produced by Aspergillus and Penicillu...
GSK-3β inhibitor.
p53 activator, IMPDH and SIRT1 inhibitor.
Fluoroquinolone; bacterial DNA gyrase inhibitor...
VEGFR1/2/3, PDGFR, c-Kit, RET inhibitor.
Cyclic tetrapeptide; HDAC inhibitor.
Ansamycin; bacterial DNA-dependent RNA polymera...
Curcumin derivative.
D2/3 agonist.
σ1 antagonist.
Benzimidazole; microtubule polymerization inhib...
Endogenous peptide hormone, involved in secreti...